Synthesis and N-Methyl-d-aspartate (NMDA) Receptor Activity of Ketamine Metabolites.

Patrick J MorrisRuin MoaddelPanos ZanosCurtis E MooreTodd D GouldCarlos A ZarateCraig J Thomas

Published in: Organic letters (2017)

Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-d-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.

Keyphrases

ms ms
endothelial cells
pain management
major depressive disorder
induced pluripotent stem cells
dna binding
transcription factor